Supratentorial glioblastoma treated with radiotherapy: Use of the radiation therapy oncology group recursive partitioning analysis grouping for predicting survival

Japanese Journal of Clinical Oncology

Volumn 40, Issue 8, 2010, Pages 726-731

  Fujii, Osamu ^a   Soejima, Toshinori ^a   Kuwatsuka, Yoko ^a   Harada, Aya ^a   Ota, Yosuke ^a   Tsujino, Kayoko ^a   Sasaki, Masato ^a   Kudo, Hiroshi ^a   Nishihara, Masamitsu ^b   Taomoto, Katsushi ^c  

^a HYOGO CANCER CENTER   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Ohnishi Neurological Center   (Japan)

Author keywords

Glioblastoma; Radiotherapy; Recursive partitioning analysis

Indexed keywords

BETA INTERFERON; CARBOPLATIN; CISPLATIN; CYTARABINE; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; METHOTREXATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CLN IGG; NIMUSTINE; PICIBANIL; PROCARBAZINE; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; AGED; ARTICLE; BASAL GANGLION; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER SIZE; CANCER SURVIVAL; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MODEL; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; RADIATION DOSE; RECURSIVE PARTITIONING ANALYSIS MODEL; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOTHERAPY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955257451     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyq051     Document Type: Article

References (17)

1. Curran WJ, Jr, Scott CB, Harton J, Nelson JS, Weinstein AS, Fiscbach J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Oncology Group malignant glioma trials. J Natl Cancer Inst 1993;85:704-10.
2. Medical Research Council Brain Tumour Working Party. Prognostic factors for high-grade malignant glioma: development of a prognostic index. J Neurooncol 1990;9:47-55.
3. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001;95:190-8.
4. Shikama N, Sasaki S, Shinoda A. Prognostic factors of patients with glioblastoma (Recursive Partitioning Analysis: RPA classes 5-6). Int J Radiat Oncol Biol Phys 2007;69(Suppl.):S252.
5. Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, Simpson JR, et al. Validation and predictive power of radiation therapy group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 1998;40:51-5.
6. Marijnen CAM, Van den Berg SMP, van Duinen SG, Voormolen JHC, Noordijk EM. Radiotherapy is effective in patients with glioblastoma multiforme with a limited prognosis and in patients above 70 years of age: a retrospective single institution analysis. Radiother Oncol 2005;75:210-6.
7. Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 Phase III randomized trial. J Clin Oncol 2006;24:2563-9.
8. Talos IF, Zou KH, Ohno-Machado L, Bhagwat JG, Kikinis R, Black PM, et al. Supratentorial low-grade glioma resectability: statistical predictive analysis based on anatomic MR features and tumor characteristics. Radiology 2006;239:506-13.
9. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive radiation therapy oncology group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 1993;26:239-44.
10. Shinoda J, Sakai N, Murase S, Yano H, Matsuhisa T, Funakoshi T. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection. J Neurooncol 2001;52:161-71.
11. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 2008;62:564-76.
12. Stupp R, Mason WP, Van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
13. Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH, et al. Randomized comparison of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980;23:1323-9.
14. Takakura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuchi K, et al. Effect of ACNU and radiotherapy on malignant glioma. J Neurosurg 1986;64:53-7.
15. Stewart LA, Glioma Meta-analysis Trialists Group. Chemotherapy in adult high-grade glioma: a systemic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 2002;359:1011-8.
16. Sultanem K, Patrocinio H, Lambert C, Corns R, Leblanc R, Parker W, et al. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial. Int J Radiat Oncol Biol Phys 2004;58:247-52.
17. Hagiwara H, Sato GH. Human × human hybridoma producing monoclonal antibody against autologous cervical carcinoma. Mol Biol Med 1983;1:245-52.